<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Cardiovascular and <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal diseases</z:e> share common risk factors </plain></SENT>
<SENT sid="1" pm="."><plain>We used structural equation modelling (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) to evaluate the independent and combined effects of phenotypes and genotypes implicated in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> on renal function in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: 1,188 type 2 diabetic patients were stratified into high-risk and low-risk groups according to bimodal distributions of the logarithmically transformed (log(e)) urinary albumin:<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio and plasma <z:chebi fb="0" ids="16737">creatinine</z:chebi> levels </plain></SENT>
<SENT sid="3" pm="."><plain>Models for these groups, comprising continuous and non-ranking categorical data, were developed separately to evaluate the inter-relationships among measured variables and latent factors using non-linear <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEMs</z:e>, Bayesian estimation and model selection as assessed by a goodness-of-fit statistic </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Inter-correlated measured variables (<z:hpo ids='HP_0001513'>obesity</z:hpo>, glycaemia, <z:chebi fb="23" ids="18059">lipid</z:chebi>, blood pressure) and variants of the genes encoding endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (NOS), beta-adrenergic receptor (ADRB), components of the renin-angiotensin system (<z:mp ids='MP_0011356'>RAS</z:mp>) and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism were loaded onto their respective latent factors of phenotypes and genotypes </plain></SENT>
<SENT sid="5" pm="."><plain>In addition to direct and indirect effects, latent factors of <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:chebi fb="23" ids="18059">lipid</z:chebi> and BP interacted with latent factors of ADRB and <z:mp ids='MP_0011356'>RAS</z:mp> genotypes to influence renal function </plain></SENT>
<SENT sid="6" pm="."><plain>Together with variants of the genes encoding peroxisome proliferator-activated receptor gamma, atrial natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi>, adducin, G protein beta(3) subunit, epithelial <z:chebi fb="199" ids="26708">sodium</z:chebi> channel alpha subunit and matrix metallopeptidase 3, these parameters explained 39-80% of the variance in renal function in the high-risk and low-risk models </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e> is a useful tool for confirming and quantifying multiple interactions of biological pathways with genetic determinants </plain></SENT>
<SENT sid="8" pm="."><plain>The combined and interactive effects of blood pressure, <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:hpo ids='HP_0001513'>obesity</z:hpo> on renal function may have therapeutic implications, especially in type 2 diabetic individuals with genetic risk factors </plain></SENT>
</text></document>